These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17544036)

  • 1. Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation.
    Nguyen LL
    J Vasc Surg; 2007 Jun; 45 Suppl A(Suppl A):A149-57. PubMed ID: 17544036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease.
    Jaff MR; Cahill KE; Yu AP; Birnbaum HG; Engelhart LM
    Ann Vasc Surg; 2010 Jul; 24(5):577-87. PubMed ID: 20579582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
    de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
    Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.
    Regensteiner JG; Hiatt WR; Coll JR; Criqui MH; Treat-Jacobson D; McDermott MM; Hirsch AT
    Vasc Med; 2008 Feb; 13(1):15-24. PubMed ID: 18372434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation.
    Spronk S; White JV; Ryjewski C; Rosenblum J; Bosch JL; Hunink MG
    J Vasc Surg; 2009 May; 49(5):1217-25; discussion 1225. PubMed ID: 19394551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular intervention for treatment of claudication: is it cost-effective?
    O'Brien-Irr MS; Harris LM; Dosluoglu HH; Dryjski ML
    Ann Vasc Surg; 2010 Aug; 24(6):833-40. PubMed ID: 20638623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical outcomes studies in peripheral vascular disease.
    Murphy TP
    J Vasc Interv Radiol; 1998; 9(6):879-89. PubMed ID: 9840031
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital.
    Janne d'Othée B; Morris MF; Powell RJ; Bettmann MA
    Cardiovasc Intervent Radiol; 2008; 31(1):56-65. PubMed ID: 17973158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease.
    Crowther RG; Spinks WL; Leicht AS; Sangla K; Quigley F; Golledge J
    J Vasc Surg; 2008 Feb; 47(2):303-9. PubMed ID: 18241753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
    Bronas UG; Hirsch AT; Murphy T; Badenhop D; Collins TC; Ehrman JK; Ershow AG; Lewis B; Treat-Jacobson DJ; Walsh ME; Oldenburg N; Regensteiner JG;
    Vasc Med; 2009 Nov; 14(4):313-21. PubMed ID: 19808716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validity of a disease-specific health status questionnaire: the peripheral artery questionnaire.
    Hoeks SE; Smolderen KG; Scholte Op Reimer WJ; Verhagen HJ; Spertus JA; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):371-7. PubMed ID: 19028064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease.
    Crowther RG; Spinks WL; Leicht AS; Quigley F; Golledge J
    J Vasc Surg; 2007 Jun; 45(6):1172-8. PubMed ID: 17543681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk.
    Ramos R; Quesada M; Solanas P; Subirana I; Sala J; Vila J; Masiá R; Cerezo C; Elosua R; Grau M; Cordón F; Juvinyà D; Fitó M; Isabel Covas M; Clarà A; Angel Muñoz M; Marrugat J;
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):305-11. PubMed ID: 19515589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of peripheral arterial disease and intermittent claudication.
    Schainfeld RM
    J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Nylaende M; Abdelnoor M; Stranden E; Morken B; Sandbaek G; Risum Ø; Jørgensen JJ; Lindahl AK; Arnesen H; Seljeflot I; Kroese AJ
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):3-12. PubMed ID: 17055756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding "Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention".
    Canaud L; Alric P
    J Vasc Surg; 2009 Aug; 50(2):476. PubMed ID: 19631900
    [No Abstract]   [Full Text] [Related]  

  • 18. Community trial of home-based exercise therapy for intermittent claudication.
    Mouser MJ; Zlabek JA; Ford CL; Mathiason MA
    Vasc Med; 2009 May; 14(2):103-7. PubMed ID: 19366815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
    Myers SA; Johanning JM; Stergiou N; Lynch TG; Longo GM; Pipinos II
    J Vasc Surg; 2008 Mar; 47(3):550-555. PubMed ID: 18207355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.